PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
C Zoccali Selected Research
Chronic Kidney Failure (Chronic Renal Failure)
10/2007
Circulating E-selectin as a risk marker in patients with end-stage renal disease.
12/2006
Asymmetric dimethylarginine in end-stage renal disease patients: a biomarker modifiable by calcium blockade and angiotensin II antagonism?
08/2006
Low triiodothyronine and survival in end-stage renal disease.
04/2006
Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease.
01/2006
Homocysteine and risk in end-stage renal disease: a matter of context.
07/2005
Leptin in end stage renal disease (ESRD): a link between fat mass, bone and the cardiovascular system.
08/2003
Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure.
07/2003
Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure.
12/2001
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.
11/2001
Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.
11/2000
Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease.
Articles by Research Topic
Disease
11
Chronic Kidney Failure (Chronic Renal Failure)
10/2007 - 11/2000
3
Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
07/2003 - 02/2001
3
Hypertension (High Blood Pressure)
03/2001 - 05/2000
2
Kidney Diseases (Kidney Disease)
01/2008 - 01/2008
2
Disease Progression
06/2007 - 01/2000
2
Inflammation
07/2003 - 11/2000
1
Cardiomyopathies (Cardiomyopathy)
03/2008
1
Carotid Artery Diseases
07/2001
1
Anoxia (Hypoxia)
02/2001
Drug/Important Bio-Agent (IBA)
2
N,N-dimethylarginine (asymmetric dimethylarginine)
IBA
01/2008 - 12/2006
2
urotensin II
IBA
01/2008 - 04/2006
2
Leptin
IBA
07/2005 - 08/2000
2
Fibrinogen (Factor I)
IBA
08/2003 - 07/2003
1
Ouabain (G Strophanthin)
IBA
03/2008
1
Simvastatin (Zocor)
FDA Link
Generic
01/2008
1
E-Selectin
IBA
10/2007
1
Adiponectin
IBA
06/2007
1
Angiotensin II
IBA
12/2006
1
Calcium
IBA
12/2006
1
Triiodothyronine (Liothyronine)
FDA Link
08/2006
1
Homocysteine
IBA
01/2006
1
dimethylarginine
IBA
12/2001
1
Brain Natriuretic Peptide (Natrecor)
FDA Link
11/2001
1
pentosidine
IBA
07/2001
1
Adrenomedullin
IBA
03/2001
1
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
11/2000
1
Endothelin-1 (Endothelin 1)
IBA
05/2000
1
adducin
IBA
01/2000
Therapy/Procedure
2
Renal Dialysis (Hemodialysis)
07/2001 - 02/2001
1
Continuous Ambulatory Peritoneal Dialysis (CAPD)
07/2001